Literature DB >> 25497070

Hospital readmission after pulmonary lobectomy is not affected by surgical approach.

Roland Assi1, Daniel J Wong1, Daniel J Boffa1, Frank C Detterbeck1, Zuoheng Wang2, Geoffrey L Chupp3, Anthony W Kim4.   

Abstract

BACKGROUND: The aim of this study is to identify the predictors of hospital readmission or early unplanned return to clinic within 30 days of discharge after pulmonary lobectomy.
METHODS: The medical records of patients undergoing lobectomy by the thoracic surgery service between January 2009 and July 2012 were reviewed. All lobectomies were included irrespective of the etiology of disease. Multivariate logistic regression methods were used to identify predictors of readmission and or early unplanned return to clinic.
RESULTS: Two hundred thirteen patients underwent a pulmonary lobectomy during the study period (median age, 67 years). Pathologic diagnosis was malignant in 94% of the patients and benign in 6%. Minimally invasive approaches were used in 69% of the patients, whereas open thoracotomy was used in 31%. Median hospital length of stay was 4 days, and postoperative mortality occurred in 1 patient (0.5%). The Charlson comorbidity index was 1 ± 1. Predicted postoperative forced expiratory volume in 1 second and diffusing capacity of the lung for carbon monoxide were 68% ± 18% and 64% ± 17%, respectively. Postoperative complications occurred in 31% of patients; 13% required readmission to the hospital within 30 days of discharge or early unplanned return to clinic. Predictors of readmission or early unplanned return to clinic were unplanned transfer to the intensive care unit (odds ratio, 10.4; 95% confidence interval, 1.1 to 103.5; p = 0.04) and Charlson comorbidity index greater than 0 (odds ratio, 1.5; 95% confidence interval, 1.04 to 2.03; p = 0.03). Readmission or early unplanned return to clinic was independent of surgical approach (p = 0.32).
CONCLUSIONS: Patients who require a postoperative transfer to the intensive care unit or with higher Charlson comorbidity index are at higher risk for hospital readmission after pulmonary lobectomy. Readmission was not affected by the surgical approach. Whether a different strategy to follow-up for these high-risk patients can prevent readmission remains to be determined.
Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25497070     DOI: 10.1016/j.athoracsur.2014.10.014

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Socioeconomic Factors Are Associated With Readmission After Lobectomy for Early Stage Lung Cancer.

Authors:  Rachel L Medbery; Theresa W Gillespie; Yuan Liu; Dana C Nickleach; Joseph Lipscomb; Manu S Sancheti; Allan Pickens; Seth D Force; Felix G Fernandez
Journal:  Ann Thorac Surg       Date:  2016-07-29       Impact factor: 4.330

2.  Intensive care unit (ICU) readmission after major lung resection: Prevalence, patterns, and mortality.

Authors:  Jae Jun Jung; Jong Ho Cho; Tae Hee Hong; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Young Mog Shim; Jae Ill Zo
Journal:  Thorac Cancer       Date:  2016-12-07       Impact factor: 3.500

3.  Prophylactic octreotide does not reduce the incidence of postoperative chylothorax following lobectomy: Results from a retrospective study.

Authors:  Chu Zhang; Hui Zhang; Wenbin Wu; Dong Liu; Dunpeng Yang; Miao Zhang; Cuntao Lu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.